Sorry, you need to enable JavaScript to visit this website.

Lyrica U.S. Post Marketing Commitment Clinical Trials and Additional Investigational Trials Recruiting Patients

July 2015

A listing of U.S. post marketing commitment clinical trials under investigation that are currently recruiting patients or pending recruitment can be found below. For additional information on these trials, including information on potential patient participation in these trials, please click on the links provided.

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures

A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures

 

There is also an additional Pfizer-sponsored, investigational, pregabalin study that is recruiting patients in the United States that is not post marketing commitment:

A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures

 

For a listing of all ongoing clinical trials for Lyrica or to enroll a patient(s) in additional ongoing Lyrica clinical trials, please go to www.clinicaltrials.gov and search for ‘Lyrica’ or ‘pregabalin’.